Internal Medicine, Endocrinology, Diabetes, & Metabolism · Sterling Heights, MI
NPI
1427077916
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
0
Medicare group memberships
Hospitals
5
Hospital affiliations
38731 Mound Road, Suite 200
Sterling Heights, MI, 48310
Phone (586) 939-8480
Medicare paid, 2024
$102K
2,501 services
Medicare patients, 2024
540
Average age 74
Drug cost, 2024
$3.3M
7,100 prescriptions
Company payments, 2025
$2,792
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nancy J Andrews was code 82962 (clinical chemistry), 603 times for 255 patients. In total Nancy J Andrews billed 2,501 services in 17 codes, and Medicare paid $102K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-11-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 82962 Clinical Chemistry | Office | 603 | 255 | $3.18 | $1,920 |
| 83036 Blood Count | Office | 593 | 254 | $9.43 | $5,590 |
| 99214 Office E&M - Established | Office | 560 | 246 | $96.63 | $54K |
| 99213 Office E&M - Established | Office | 407 | 311 | $63.80 | $26K |
| 95251 Test - Miscellaneous | Office | 178 | 80 | $27.21 | $4,843 |
| 97535 Occupational Therapy | Office | 73 | 28 | $26.64 | $1,945 |
| 99204 Office E&M - New | Office | 22 | 22 | $124.24 | $2,733 |
| 77080 Standard X-ray | Office | 19 | 19 | $39.73 | $755 |
By year: 2022 $137K for 3,058 services; 2023 $128K for 3,166 services; 2024 $102K for 2,501 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 603 | 255 | $3.18 | $1,920 |
| 83036 Blood Count | 593 | 254 | $9.43 | $5,590 |
Medicare prescription drug claims, 2024
In 2024, the drug Nancy J Andrews prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,196 prescriptions and refills. In total Nancy J Andrews wrote 7,100 Medicare prescriptions that cost $3.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,196 | 3,351 | 349 | $15K |
| Metformin Hcl Generic | 419 | 1,211 | 134 | $4,985 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 382 | 1,056 | 134 | $71K |
| Jardiance Empagliflozin | 293 | 731 | 85 | $407K |
| Synthroid Levothyroxine Sodium | 252 | 728 | 80 | $31K |
| Ozempic Semaglutide | 242 | 559 | 71 | $510K |
| Trulicity Dulaglutide | 235 | 511 | 65 | $486K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 232 | 621 | 97 | $31K |
| Novolog Flexpen Insulin Aspart | 192 | 483 | 85 | $80K |
| Ultra-Fine Nano Pen Needle Pen Needle, Diabetic | 152 | 434 | 61 | $16K |
| Atorvastatin Calcium Generic | 150 | 426 | 50 | $2,076 |
| Humalog Kwikpen U-100 Insulin Lispro | 148 | 417 | 61 | $68K |
| Farxiga Dapagliflozin Propanediol | 129 | 318 | 35 | $167K |
| Tresiba Flextouch U-100 Insulin Degludec | 124 | 353 | 46 | $112K |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 122 | 357 | 49 | $97K |
Brand drugs: 3,878 claims; generic drugs: 2,565 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nancy J Andrews $2,792 ($2,792 in general payments such as food, travel and fees) from 28 companies. The largest payer was Novo Nordisk Inc with $363.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 23 | $363 |
| Amgen Inc. AMGN | 22 | $302 |
| Chiesi USA, Inc. | 1 | $300 |
| Mannkind Corporation MNKD | 16 | $274 |
| Ascensia Diabetes Care Us Inc. | 20 | $208 |
| Radius Health, Inc. | 7 | $161 |
| Neurocrine BioSciences, Inc. NBIX | 5 | $116 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $111 |
| Abbvie Inc. ABBV | 5 | $107 |
| Amneal Pharmaceuticals LLC AMRX | 6 | $105 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.